CBST-affiliated researchers receive an $8.5M NIH/NIBIB grant to establish a center
dedicated to developing and evaluating novel point-of-care diagnostic technologies. We are developing robust, minimally-invasive, photon-based biosensors for in vivo or ex vivo detection of pathogens, metabolites, vitals, and cardiac biomarkers.

Photon-based technologies will greatly benefit from recent initiatives such as the NIBIB U54 Point-of-Care Research Network. These instruments can augment the capabilities of disaster medical assistance teams, and provide minimally-invasive monitoring in critical and emergency care environments.

Artist impression of rapid pathogen DNA detector using loopmediated isothermal amplification (LAMP)